CPI-637
CPI-637 is a cell-permeable benzodiazepinone compound that acts as a selective inhibitor of the CBP and EP300 bromodomains. It is utilized in epigenetic research to probe the roles of these acetyl-lysine readers in cellular processes and has been applied in both in vitro biochemical assays and in vivo model studies.
Product Specifications
CAS Number
1884712-47-3
Product Name Alternative
CBP, BRD4, CPI-637, CPI637, CPI 637, Epigenetic Reader Domain, EpigeneticReaderDomain, EP300, HistoneAcetyltransferase, Histone Acetyltransferase, HAT, HATs, Inhibitor, inhibit
Field of Research
Epigenetics & Chromatin
Purity
99.75% (May vary between batches)
Solubility
Ethanol:< 1 mg/mL (insoluble or slightly soluble) ; DMSO:3.87 mg/mL (10.01 mM) ; H2O:< 1 mg/mL (insoluble or slightly soluble)
Smiles
C[C@@H]1CC (=O) Nc2cccc (-c3ccc4n (C) nc (-c5cnn (C) c5) c4c3) c2N1
Molecular Formula
C22H22N6O
Molecular Weight
386.45
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog